penicillamine has been researched along with rig 200 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, AR; Gray, GA; Greig, IR; Megson, IL; Webb, DJ | 1 |
| Butler, AR; Mazzei, FA; Megson, IL; Miller, MR; Roseberry, MJ; Webb, DJ | 2 |
| Campanella, C; Megson, IL; Sogo, N; Webb, DJ | 1 |
| Butler, AR; Mazzei, FA; Megson, IL; Sogo, N; Walton, JC; Webb, DJ | 1 |
| Magid, KS; Megson, IL; Shaw, CA; Sogo, N; Webb, DJ | 1 |
6 other study(ies) available for penicillamine and rig 200
| Article | Year |
|---|---|
Therapeutic potential of S-nitrosothiols as nitric oxide donor drugs.
Topics: Animals; Glucosamine; Humans; Nitric Oxide; Nitroso Compounds; Penicillamine; Rats; S-Nitroso-N-Acetylpenicillamine; Vasodilator Agents | 1997 |
Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryl trinitrate-tolerant rat femoral arteries.
Topics: Animals; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; Femoral Artery; Glucosamine; Glutathione; Hemoglobins; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroglycerin; Nitroso Compounds; Oxadiazoles; Penicillamine; Perfusion; Phenylephrine; Quinoxalines; Rats; Rats, Wistar; S-Nitrosoglutathione; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.
Topics: Acetylcholine; Coronary Artery Bypass; Coronary Disease; Enzyme Inhibitors; Glucosamine; Glutathione; Humans; Mammary Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroso Compounds; Penicillamine; Platelet Aggregation Inhibitors; S-Nitrosoglutathione; Saphenous Vein; Vasodilation; Vasodilator Agents | 2000 |
Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.
Topics: Adult; Cyclic GMP; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Erythrocytes; Fibrinolytic Agents; Glucosamine; Glutathione; Hemoglobins; Humans; Male; Mercaptoethanol; Nitric Oxide; Nitroso Compounds; Penicillamine; Platelet Aggregation; Platelet Aggregation Inhibitors; S-Nitrosoglutathione; S-Nitrosothiols | 2000 |
Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteries.
Topics: Animals; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; Femoral Artery; Glucosamine; Glutathione; Guanylate Cyclase; In Vitro Techniques; Male; Methemoglobin; Nitric Oxide Donors; Nitroglycerin; Nitroso Compounds; Oxadiazoles; Penicillamine; Phenylephrine; Quinoxalines; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Vasoconstrictor Agents; Vasodilation | 2000 |
Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Collagen; Cyclic GMP; Enzyme Inhibitors; Glucosamine; Glutathione; Humans; In Vitro Techniques; Kinetics; Models, Biological; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Nitroso Compounds; Oxadiazoles; Penicillamine; Platelet Aggregation; Platelet Aggregation Inhibitors; Quaternary Ammonium Compounds; Quinoxalines; S-Nitrosoglutathione | 2000 |